The Hartford Healthcare Fund Class F (HGHFX)
| Fund Assets | 788.79M |
| Expense Ratio | 0.92% |
| Min. Investment | $0.00 |
| Turnover | 40.00% |
| Dividend (ttm) | 2.11 |
| Dividend Yield | 5.84% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 27, 2024 |
| Previous Close | 36.51 |
| YTD Return | -5.90% |
| 1-Year Return | -14.55% |
| 5-Year Return | 7.06% |
| 52-Week Low | 34.93 |
| 52-Week High | 47.07 |
| Beta (5Y) | n/a |
| Holdings | 91 |
| Inception Date | Feb 28, 2017 |
About HGHFX
The Hartford Healthcare Fund Class F is an open-end mutual fund focused on delivering long-term capital appreciation by investing primarily in the global healthcare sector. Managed by an experienced team from Wellington Management, the fund allocates at least 80% of its assets to equity securities of companies engaged in healthcare-related industries, encompassing pharmaceuticals, biotechnology, medical technology, healthcare services, and emerging healthcare subsectors. The portfolio is broadly diversified, typically holding around 100 stocks, with substantial exposure to large-cap healthcare firms while also investing in mid- and small-cap companies to capture sector innovation and growth opportunities. Notable portfolio holdings include leading names such as Eli Lilly & Co., UnitedHealth Group, and Merck & Co. The fund emphasizes U.S. equities but also maintains exposure to international healthcare companies, reflecting the sector’s global scope. With annual operating expenses around 0.91% and an active share of approximately 44%, the Hartford Healthcare Fund Class F plays a significant role for investors seeking targeted exposure to healthcare markets, leveraging sector expertise and active management to capitalize on trends and advancements within the industry.
Performance
HGHFX had a total return of -14.55% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.96%.
Top 10 Holdings
46.52% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.89% |
| UnitedHealth Group Incorporated | UNH | 6.80% |
| Boston Scientific Corporation | BSX | 4.90% |
| Intuitive Surgical, Inc. | ISRG | 4.17% |
| Merck & Co., Inc. | MRK | 3.69% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.34% |
| Johnson & Johnson | JNJ | 2.91% |
| Cencora, Inc. | COR | 2.89% |
| Gilead Sciences, Inc. | GILD | 2.47% |
| Thermo Fisher Scientific Inc. | TMO | 2.46% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2024 | $0.2154 | Dec 30, 2024 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |